Skip to main content

Oncocyte: Medical Advisory Board

Oncocyte said it has formed a new medical advisory board to advise the company on the development and clinical advancement of its portfolio of tests, including its immuno-oncology and blood-based monitoring tests.

Chairing the MAB is David Gandara, professor of medicine emeritus at the UC Davis School of Medicine. Gandara is a recognized authority in biomarker research and drug development in oncology, with extensive experience in translational research in lung cancer. Other board members include Daniel Hayes, professor at the University of Michigan Rogel Cancer Center; Fred Hirsch, executive director at the Center of Thoracic Oncology in the Tisch Cancer Institute at Mount Sinai and professor of medicine at the Icahn School of Medicine; Heinz-Josef Lenz, co-leader of the gastrointestinal cancers program at the USC Norris Comprehensive Cancer Center; and Ignacio Wistuba, chair of the department of translational molecular pathology at The University of Texas MD Anderson Cancer Center.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.